Masterone Enanthate 200 (10 ml)

Masterone Enanthate 200 (10 ml)

Manufacturer: Euro-Pharmacies
Package: 10 ml
Dosage: 200 mg/ml
Common Names: Masterone Enanthate 200, Masteron Enanthate, Drostanolone Enanthate, Masteron E, Mast E, Drostanolone Enanthate 200 mg/ml

Info: (EP) Masterone Enanthate 200 from Euro-Pharmacies contains Drostanolone Enanthate, a long-acting ester of drostanolone, a synthetic anabolic-androgenic steroid structurally derived from dihydrotestosterone (DHT). Drostanolone binds to androgen receptors and exhibits both anabolic and androgenic activity. Unlike testosterone, drostanolone is not directly converted into estrogen through aromatization. The enanthate ester provides prolonged release of the active substance.

Effects

Anabolic Activity: Drostanolone interacts with androgen receptors and influences physiological processes associated with protein synthesis and muscle metabolism. The extent of these effects depends on individual factors and exposure.

Androgenic Activity: As a DHT derivative, drostanolone has androgenic properties that may affect the skin, hair follicles, and reproductive function.

Side Effects

Potential adverse effects associated with drostanolone may include acne, oily skin, hair loss in genetically susceptible individuals, changes in libido, and mood disturbances. Use may also suppress endogenous testosterone production, impair fertility, and adversely affect lipid profiles. Other potential concerns include elevated blood pressure and increased cardiovascular risk. In women, androgenic effects may include voice deepening, increased body hair, and menstrual irregularities; some changes may be irreversible.

Dosage Range and Duration of Use

Masterone Enanthate 200 contains 200 mg of drostanolone enanthate per ml in an oil-based injectable formulation. Drostanolone enanthate is not an approved human medicinal product in many jurisdictions. In non-medical performance and physique settings, reported dosages typically range from 200 mg to 400 mg per week, divided into one or two deep intramuscular injections. Due to the long-acting enanthate ester, experimental cycles commonly extend over 8 to 12 weeks to achieve stable concentrations of the active substance in the blood. These practices are not supported by sufficient clinical evidence to establish safety or efficacy.  

Combination with Other Drugs

Drostanolone may present additional risks when combined with other anabolic-androgenic steroids, androgenic medicines, or substances that affect hormonal function. Such combinations may increase the likelihood of testosterone suppression, impaired fertility, adverse lipid changes, elevated blood pressure, and other cardiovascular complications. Interactions may also be relevant with anticoagulants and medicines affecting metabolic or cardiovascular parameters.